Jiangsu Gdk Biotechnology Co., Ltd. Class ASSE: 688670

"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 10, 2026 · Issued by Jiangsu Gdk Biotechnology Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Jiangsu Gdk Biotechnology Co., Ltd. Class A

"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026Aug 21
"JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD."Announcement on Renewal of Joint Control and Concerted Action Agreement by Controlling Shareholder and Joint Actual ControllersAug 4
Announcement on Reply to Regulatory Inquiry Letter Regarding Information Disclosure of 2025 Annual ReportJun 8
Announcement on Resolutions of the 2025 Annual General MeetingMay 15

All Jiangsu Gdk Biotechnology Co., Ltd. Class A news releases